On Air Now

Listen

Listen Live Now » 101.9 FM Central Wisconsin

Weather

Current Conditions(Wausau,WI 54403)

More Weather »
60° Feels Like: 60°
Wind: W 3 mph Past 24 hrs - Precip: 0.01”
Current Radar for Zip

Tonight

Clear 53°

Tomorrow

Mostly Sunny 75°

Wed Night

Clear 53°

Alerts

Oncothyreon lung cancer drug fails in late-stage trial

(Reuters) - Biopharmaceutical company Oncothyreon Inc said a late-stage trial of its experimental lung cancer drug did not meet the main study goal of improving overall survival.

The drug, codenamed L-BLP25, is being tested in patients with unresectable, locally advanced stage IIIA or stage IIIB, non-small cell lung cancer (NSCLC).

The trial was conducted by Merck Serono, a division of Germany's Merck KGaA, under a license agreement with Oncothyreon.

(Reporting by Esha Dey in Bangalore; Editing by Roshni Menon)

Comments